About this trial
The regional health authorities of South-East Norway has commissioned Sørlandet Hospital (SSHF), Norway to establish mechanical thrombectomy in large-vessel occlusion stroke. SSHF is a limited volume stroke center, and introduction of thrombectomy may impose quality challenges. Therefore the implementation will be guided by a simulation based quality assurance program. In this study, we will monitor timelines, technical and clinical outcomes, including adverse events.
Eligibility criteria
Qualifiers
Adult patients
Large vessel occlusion stroke
Disqualifiers
Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area
More than 24 hours after stroke onset
Trial design
Treatments tested in this trial
- Simulation based quality program
Treatment groups
Sponsors and collaborators
Sorlandet Hospital HF
Lead sponsor
South-Eastern Norway Regional Health Authority
Collaborator
Helse Stavanger HF
Collaborator
University of Stavanger
Collaborator